Status:
TERMINATED
Identification and Characterization of Molecular Markers in Musculoskeletal Tumors
Lead Sponsor:
Balgrist University Hospital
Conditions:
Soft Tissue and Bone Tumors
Sarcoma
Eligibility:
All Genders
Brief Summary
The aim of the study is to improve the understanding of molecular mechanisms in the development and progression of musculoskeletal tumors. These tumors do have in general unfavorable prognosis and con...
Detailed Description
To definitely asses such molecular markers in musculoskeletal tumors they have to be identified in human patient samples with corresponding tumors, before molecular markers can be validated in animal ...
Eligibility Criteria
Inclusion
- surgery or biopsy of a bone- or soft tissue tumor
- informed consent
Exclusion
- patients wish
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02199938
Start Date
January 1 2010
End Date
July 1 2018
Last Update
October 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Balgrist University Hospital
Zurich, Switzerland, 8008